Registry on Luma Vision's VERAFEYE System (ENLIgHT)

Sponsor
LUMA Vision Ltd.
Study ID
NCT06293430
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • VERAFEYE System — DEVICE
    VERAFEYE system guidance will be used on all patients undergoing AF ablation and/or LAAC procedures.

Study Details

The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.

Key Dates

First listed
Mar 5, 2024
Start date
Feb 15, 2027
Status verified
Jul 2026
Primary completion
Oct 15, 2027
Completion
Oct 15, 2027

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Acute procedural success rates during the index procedure [ Time Frame: During the procedure ]

Central Contacts

Find similar trials

Nationwide
Atrial fibrillation trialsCardiology trialsHeart disease trials

Related Studies